litlas
Log inCreate account

Valter Torri

Active 1986–2025

156
Papers
36,566
Citations
89
h-index
154
i10-index

Citations

Citations per year for Valter Torri1971: 2 citations1973: 1 citations1990: 1 citations1991: 7 citations1992: 5 citations1993: 13 citations1994: 2 citations1995: 5 citations1996: 9 citations1997: 15 citations1998: 25 citations1999: 32 citations2000: 49 citations2001: 64 citations2002: 85 citations2003: 84 citations2004: 102 citations2005: 115 citations2006: 120 citations2007: 140 citations2008: 144 citations2009: 203 citations2010: 236 citations2011: 256 citations2012: 293 citations2013: 325 citations2014: 316 citations2015: 326 citations2016: 268 citations2017: 276 citations2018: 229 citations2019: 946 citations2020: 1,148 citations2021: 1,173 citations2022: 863 citations2023: 628 citations2024: 1,039 citations2025: 468 citations2026: 10 citations1972: no citations, so this year is not shown1974–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,102 citing papers, 19.6% of this breakdownChina: 1,581 citing papers, 10% of this breakdownUnited Kingdom: 1,471 citing papers, 9.3% of this breakdownItaly: 1,468 citing papers, 9.2% of this breakdownGermany: 778 citing papers, 4.9% of this breakdownFrance: 731 citing papers, 4.6% of this breakdownCanada: 630 citing papers, 4% of this breakdownNetherlands: 572 citing papers, 3.6% of this breakdownJapan: 546 citing papers, 3.4% of this breakdownSpain: 537 citing papers, 3.4% of this breakdownAustralia: 516 citing papers, 3.2% of this breakdownSwitzerland: 361 citing papers, 2.3% of this breakdown
0%19.6%Other 22.5%

Institutions

Fields

  • Medicine79.6%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology4.1%
  • Health Professions0.9%
  • Engineering0.8%
  • Decision Sciences0.5%
  • Other3.5%

Topics

  • Cancer Immunotherapy and Biomarkers3.8%
  • Colorectal Cancer Treatments and Studies3.8%
  • Lung Cancer Treatments and Mutations3.5%
  • Lung Cancer Diagnosis and Treatment2.9%
  • Genetic factors in colorectal cancer2.5%
  • Ovarian cancer diagnosis and treatment2.4%
  • Other81.1%

Coauthors

All papers

Open in search
  1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

    Authors: Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen Spiro, Estelle Rolland, Roldano Fossati, D. Aubert, Keyue Ding, David Waller, Thierry Le Chevalier - Journal of Clinical Oncology 2008 cited by 2,670

  2. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

    Authors: Mahesh Parmar, Valter Torri, Lesley Stewart - Statistics in Medicine 1998 cited by 4,831

  3. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

    Authors: Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Francesca Bergamo, Vittorina Zagonel, Francesco Leone, Ilaria Depetris, Erika Martinelli, Teresa Troiani, Fortunato Ciardiello, Patrizia Racca, Andrea Bertotti, Giulia Siravegna, Valter Torri, Alessio Amatu, Silvia Ghezzi, Giovanna Marrapese, Laura Palmeri, Emanuele Valtorta, Andrea Cassingena, Calogero Lauricella, Angelo Vanzulli, Daniele Regge, Silvio Veronese, Paolo M. Comoglio, Alberto Bardelli, Silvia Marsoni, Salvatore Siena - The Lancet Oncology 2016 cited by 1,009

  4. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

    Authors: Claudio Vernieri, Giovanni Fucà, Francesca Ligorio, Veronica Huber, Andrea Vingiani, Fabio Iannelli, Alessandra Raimondi, Darawan Rinchai, Gianmaria Frigè, Antonino Belfiore, Luca Lalli, Claudia Chiodoni, Valeria Cancila, Federica Zanardi, Arta Ajazi, Salvatore Cortellino, Viviana Vallacchi, Paola Squarcina, Agata Cova, Samantha Pesce, Paola Frati, Raghvendra Mall, Paola Antonia Corsetto, Angela Maria Rizzo, Cristina Ferraris, Secondo Folli, Marina Chiara Garassino, Giuseppe Capri, Giulia Bianchi, Mario Paolo Colombo, Saverio Minucci, Marco Foiani, Valter Daniel Longo, Giovanni Apolone, Valter Torri, Giancarlo Pruneri, Davide Bedognetti, Licia Rivoltini, Filippo de Braud - Cancer Discovery 2021 cited by 302

  5. Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

    Authors: Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi, Benedetta Mussolin, Francesco Rua, Giovanni Crisafulli, Alice Bartolini, Elisabetta Fenocchio, Alessio Amatu, Paolo Manca, Francesca Bergamo, Federica Tosi, Gianluca Mauri, Margherita Ambrosini, Francesca Daniel, Valter Torri, Angelo Vanzulli, Daniele Regge, Giovanni Cappello, Caterina Marchiò, Enrico Berrino, Anna Sapino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli - Nature Medicine 2022 cited by 261

  6. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Authors: Axel Grothey, Alberto Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taı̈eb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca, Jeffrey A. Meyerhardt, Déwi Vernerey, Takeharu Yamanaka, Ioannis Boukovinas, Jeffrey P. Meyers, Lindsay A. Renfro, Donna Niedzwiecki, Toshiaki Watanabe, Valter Torri, Mark Saunders, Daniel J. Sargent, Thierry André, Timothy Iveson - New England Journal of Medicine 2018 cited by 1,126

  7. Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

    Authors: Daniel J. Sargent, Silvia Marsoni, Geneviève Monges, Stephen N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Amy J. French, Brian Kabat, Nathan R. Foster, Valter Torri, Christine Ribic, Axel Grothey, Malcolm Moore, Alberto Zaniboni, J. F. Seitz, Frank Sinicrope, Steven Gallinger - Journal of Clinical Oncology 2010 cited by 1,613

  8. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial

    Authors: Andrea Sartore‐Bianchi, Sara Lonardi, Cosimo Martino, Elisabetta Fenocchio, Federica Tosi, Silvia Ghezzi, Francesco Leone, Francesca Bergamo, Vittorina Zagonel, Fortunato Ciardiello, Andrea Ardizzoni, Alessio Amatu, Katia Bencardino, Emanuele Valtorta, Elena Grassi, Valter Torri, Emanuela Bonoldi, Anna Sapino, Angelo Vanzulli, Daniele Regge, Giovanni Cappello, Alberto Bardelli, Livio Trusolino, Silvia Marsoni, Salvatore Siena - ESMO Open 2020 cited by 181

  9. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: Benjamin Lacas, Alexandra Carmel, C. Landais, Stuart J. Wong, Lisa Licitra, Jeffrey Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregory T. Wolf, Ricardo Hitt, Renzo Corvò, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean‐Jacques Mazeron, Lai‐ping Zhong, W. Dobrowsky, Pirus Ghadjar, C. Fallai, Branko Zakotnik, Atul Sharma, René‐Jean Bensadoun, Maria Grazia Ruo Redda, S. Racadot, George Fountzilas, David M. Brizel, P Rovea, Athanassios Argiris, Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  10. Heme catabolism by tumor-associated macrophages controls metastasis formation

    Authors: Francesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, Mariangela Storto, Paolo Kunderfranco, Alberto Termanini, Fabio Pasqualini, Chiara Alì, Chiara Pandolfo, Francesco Sgambelluri, Giulia Grazia, Mario Santinami, Andrea Maurichi, Massimo Milione, Marco Erreni, Andrea Doni, Marco Fabbri, Laura Gribaldo, Eliana Rulli, Miguel P. Soares, Valter Torri, Roberta Mortarini, Andrea Anichini, Antonio Sica - Nature Immunology 2021 cited by 124

  11. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    Authors: Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Axel Grothey, Donna Niedzwiecki, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Déwi Vernerey, Jeffrey P. Meyers, Andrea Harkin, Valter Torri, Eiji Oki, Vassilis Georgoulias, Julien Taı̈eb, Anthony F. Shields, Qian Shi - The Lancet Oncology 2020 cited by 298

  12. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

    Authors: Mahesh Parmar, Jonathan A. Ledermann, Nicoletta Colombo, Andreas du Bois, Delaloye Jf, Gunnar B. Kristensen, Sarah Wheeler, Ann Marie Swart, W. Qian, Valter Torri, Irene Floriani, Gordon C. Jayson, Alan Lamont, C. Tropé - The Lancet 2003 cited by 1,197

  13. Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

    Authors: Giuseppe Lo Russo, Massimo Moro, Michele Sommariva, Valeria Cancila, Mattia Boeri, Giovanni Centonze, Simona Ferro, Monica Ganzinelli, Patrizia Gasparini, Veronica Huber, Massimo Milione, Luca Porcu, Claudia Proto, Giancarlo Pruneri, Diego Signorelli, Sabina Sangaletti, Lucia Sfondrini, Chiara Storti, Elena Tassi, Alberto Bardelli, Silvia Marsoni, Valter Torri, Claudio Tripodo, Mario P. Colombo, Andrea Anichini, Licia Rivoltini, Andrea Balsari, Gabriella Sozzi, Marina Chiara Garassino - Clinical Cancer Research 2018 cited by 407

  14. HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer

    Authors: Andrea Sartore‐Bianchi, Alessio Amatu, Luca Porcu, Silvia Ghezzi, Sara Lonardi, Francesco Leone, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli, Beatrice Borelli, Federica Tosi, Patrizia Racca, Emanuele Valtorta, Emanuela Bonoldi, Cosimo Martino, C. Vaghi, Giovanna Marrapese, Fortunato Ciardiello, Vittorina Zagonel, Alberto Bardelli, Livio Trusolino, Valter Torri, Silvia Marsoni, Salvatore Siena - The Oncologist 2019 cited by 169

  15. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    Authors: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Valter Torri, Christopher P. Fox, Paul La Rosée, Elisabeth Schorb, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Angela Ferrari, Kim Linton, Roberta Rudà, Mascha Binder, Tobias Pukrop, Monica Balzarotti, Alberto Fabbri, Peter Johnson, Jette Sønderskov Gørløv, Georg Heß, Jens Panse, Francesco Pisani, Alessandra Tucci, Stephan Stilgenbauer, Bernd Hertenstein, Ulrich Keller, Stefan W. Krause, Alessandro Levis, Hans‐Joachim Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2016 cited by 599

  16. Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

    Authors: Pierluigi Benedetti Panici, S. Basile, F. Maneschi, Andrea Alberto Lissoni, Mauro Signorelli, Giovanni Scambia, Roberto Angioli, Saverio Tateo, Giorgia Mangili, Dionyssios Katsaros, G Garozzo, E Campagnutta, Nicoletta Donadello, Stefano Greggi, Mauro Melpignano, Francesco Raspagliesi, Nicola Ragni, Gennaro Cormio, Roberto Grassi, Massimo Piergiuseppe Franchi, Diana Giannarelli, Roldano Fossati, Valter Torri, M. Amoroso, C. Della Croce, Costantino Mangioni - JNCI Journal of the National Cancer Institute 2008 cited by 1,550

  17. Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial

    Authors: Michele Reni, Gianpaolo Balzano, Silvia Zanon, Alessandro Zerbi, Lorenza Rimassa, R. Castoldi, D. Pinelli, Stefania Mosconi, Claudio Doglioni, Marta Chiaravalli, Chiara Pircher, Paolo Giorgio Arcidiacono, Valter Torri, Paola Maggiora, Domenica Ceraulo, Massimo Falconi, Luca Gianni - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 254

  18. LBA28 The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients

    Authors: Sara Lonardi, Filippo Pietrantonio, N. Tarazona Llavero, C. Montagut Viladot, A. Sartore Bianchi, Maria Giulia Zampino, M.E. Elez Fernandez, C. Santos Vivas, Mario Mandalà, Stefano Tamberi, M.S. Sciallero, Susana Muñoz, Luca Lazzari, Paolo Luraghi, Valter Torri, Andrés Cervantes, Alberto Bardelli, Josep Tabernero, Salvatore Siena, Silvia Marsoni - Annals of Oncology 2023 cited by 58

  19. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Authors: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Christopher P. Fox, Elisabeth Schorb, Paul La Rosée, Mascha Binder, Alberto Fabbri, Valter Torri, Eleonora Minacapelli, Monica Falautano, Fiorella Ilariucci, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Peter Johnson, Kim Linton, Tobias Pukrop, Jette Sønderskov Gørløv, Monica Balzarotti, Georg Heß, Ulrich Keller, Stephan Stilgenbauer, Jens Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Alessandro Levis, Stefan W. Krause, Hans‐Joachim Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Michael Pfreundschuh, Giuseppina Cabras, F. Angrilli, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Michele Reni, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2017 cited by 381

  20. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

    Authors: Sarah Burdett, Jean‐Pierre Pignon, Jayne F. Tierney, Hélène Tribodet, Lesley Stewart, C. Le Péchoux, Anne Aupérin, Thierry Le Chevalier, Richard Stephens, R. Arriagada, Julian P. T. Higgins, David H. Johnson, Jan P. van Meerbeeck, Mahesh Parmar, Robert L. Souhami, Bengt Bergman, Jean-Yves Douillard, Ariane Dunant, Chiaki Endo, D.J. Girling, Harubumi Kato, Steven M. Keller, Hideki Kimura, Aija Knuuttila, Ken Kodama, Ritsuko Komaki, Mark G. Kris, Thomas E. Lad, Tommaso Claudio Mineo, Steven Piantadosi, Rafael Rosell, Giorgio V. Scagliotti, Lesley Seymour, Frances A. Shepherd, Richard Sylvester, Hirohito Tada, Fumihiro Tanaka, Valter Torri, David Waller, Ying Liang, for the Non-Small Cell Lung Cancer Collaborative Group - Cochrane Database of Systematic Reviews 2015 cited by 366

  21. HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

    Authors: Filippo Pietrantonio, M. Caporale, Federica Morano, Mario Scartozzi, Annunziata Gloghini, Ferdinando De Vita, Elisa Giommoni, Lorenzo Fornaro, Giuseppe Aprile, Davide Melisi, Rosa Berenato, Alessia Mennitto, Chiara Costanza Volpi, Maria Maddalena Laterza, Valeria Pusceddu, Lorenzo Antonuzzo, Enrico Vasile, Elena Ongaro, Francesca Simionato, Filippo de Braud, Valter Torri, Maria Di Bartolomeo - International Journal of Cancer 2016 cited by 149

  22. Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

    Authors: Federica Tosi, Andrea Sartore‐Bianchi, Sara Lonardi, Alessio Amatu, Francesco Leone, Silvia Ghezzi, Cosimo Martino, Katia Bencardino, Erica Bonazzina, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli, Teresa Troiani, Giulia Siravegna, Gianluca Mauri, Valter Torri, Giovanna Marrapese, Emanuele Valtorta, Andrea Cassingena, Giovanni Cappello, Emanuela Bonoldi, Angelo Vanzulli, Daniele Regge, Fortunato Ciardiello, Vittorina Zagonel, Alberto Bardelli, Livio Trusolino, Silvia Marsoni, Salvatore Siena - Clinical Colorectal Cancer 2020 cited by 104

  23. Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

    Authors: Giovanni Fucà, Giulia Galli, M. Poggi, Giuseppe Lo Russo, Claudia Proto, Martina Imbimbo, Roberto Ferrara, Nicoletta Zilembo, Monica Ganzinelli, Antonio Sica, Valter Torri, Mario P. Colombo, Claudio Vernieri, Andrea Balsari, Filippo de Braud, Marina Chiara Garassino, Diego Signorelli - ESMO Open 2019 cited by 212

  24. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

    Authors: Silvia Stacchiotti, Alessandro Gronchi, P Fossati, T. Akiyama, C. Alapetite, Michaël Baumann, Jean‐Yves Blay, Stéphanie Bolle, Stefano Boriani, Paolo Bruzzi, Rodolfo Capanna, Augusto Caraceni, R. Casadei, Vittoria Colia, J. Debus, Thomas F. DeLaney, Atman Desai, Palma Dileo, P. D. S. Dijkstra, Francesco Doglietto, Adrienne M. Flanagan, Sébastien Froelich, Paul A. Gardner, Hans Gelderblom, Z. Gokaslan, Rick L. Haas, C. Heery, Nadia Hindi, P. Hohenberger, Francis J. Hornicek, Reiko Imai, Lee Jeys, Robin L. Jones, Bernd Kasper, Akira Kawai, Marco Krengli, A. Leithner, I. Logowska, Javier Martín‐Broto, Diego Mazzatenta, Carlo Morosi, P. Nicolai, O.J. Norum, Shreyaskumar Patel, Nicolas Penel, Piero Picci, S. Pilotti, Stefano Redaelli, F. Ricchini, Piotr Rutkowski, S. Scheipl, Chandranath Sen, E. Tamborini, Katherine A. Thornton, Beate Timmermann, Valter Torri, P.-U. Tunn, M. Uhl, Yoshiya Yamada, Damien C. Weber, D. Vanel, Péter Varga, Carmen Vleggeert‐Lankamp, Paolo G. Casali, J. Sommer - Annals of Oncology 2017 cited by 243